Loading provider…
Loading provider…
Nephrology Physician in Houston, TX
NPI: 1245339928Primary Practice Location
U.S. Renal Care Webster Dialysis
1213 Hermann Dr, Houston, TX
Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Get MD Biruh's Phone Numberphone_androidMobile
Get MD Biruh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
TX State Medical License
CA State Medical License
2005
FL State Medical License
2021
AZ State Medical License
2023 - 2026
GA State Medical License
2023 - 2026
TN State Medical License
2023 - 2026
WA State Medical License
2023 - 2026
AL State Medical License
2023 - 2025
LA State Medical License
2023 - 2025
MS State Medical License
2023 - 2025
OK State Medical License
2023 - 2025
TX State Medical License
2008 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
Stanford University School Of Medicine
med.stanford.edu
Post-Doctoral Fellowship • 2005 - 2008
2005 - 2008
McGovern Medical School
med.uth.edu
Medical School
Until 2002
Stanford Health Care-Sponsored Stanford University
Fellowship • Nephrology
2005 - 2007
University of Texas Medical Branch Hospitals
Residency • Internal Medicine
2002 - 2005
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 128 | 294 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 66 | 66 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 37 | 40 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 29 | 29 |
| 5 | 90935Hemodialysis procedure with one physician evaluation | 22 | 34 |
Authors: Michael Carstens, Sreedhar Mandayam
Journal: Stem Cells Transl Med
Efficacy of loop diuretics in the management of undocumented patients with end-stage renal disease.
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: BION-1301 Single Dose, DRUG: Placebo Single Dose, DRUG: BION-1301 Multiple Doses, DRUG: Placebo Multiple Doses
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Dulaglutide, DRUG: Insulin lispro, DRUG: Insulin glargine